"Neoplasms" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms.
| Descriptor ID |
D009369
|
| MeSH Number(s) |
C04
|
| Concept/Terms |
Neoplasms- Neoplasms
- Neoplasia
- Neoplasias
- Neoplasm
- Tumors
- Tumor
Cancer- Cancer
- Cancers
- Malignant Neoplasms
- Malignant Neoplasm
- Neoplasm, Malignant
- Neoplasms, Malignant
- Malignancy
- Malignancies
Benign Neoplasms- Benign Neoplasms
- Neoplasms, Benign
- Benign Neoplasm
- Neoplasm, Benign
|
Below are MeSH descriptors whose meaning is more general than "Neoplasms".
Below are MeSH descriptors whose meaning is more specific than "Neoplasms".
This graph shows the total number of publications written about "Neoplasms" by people in this website by year, and whether "Neoplasms" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 7 | 4 | 11 |
| 1996 | 7 | 2 | 9 |
| 1997 | 13 | 0 | 13 |
| 1998 | 16 | 2 | 18 |
| 1999 | 8 | 6 | 14 |
| 2000 | 6 | 1 | 7 |
| 2001 | 10 | 4 | 14 |
| 2002 | 21 | 8 | 29 |
| 2003 | 27 | 10 | 37 |
| 2004 | 24 | 9 | 33 |
| 2005 | 34 | 7 | 41 |
| 2006 | 22 | 5 | 27 |
| 2007 | 37 | 7 | 44 |
| 2008 | 35 | 17 | 52 |
| 2009 | 51 | 5 | 56 |
| 2010 | 55 | 14 | 69 |
| 2011 | 54 | 15 | 69 |
| 2012 | 57 | 13 | 70 |
| 2013 | 68 | 16 | 84 |
| 2014 | 95 | 18 | 113 |
| 2015 | 68 | 11 | 79 |
| 2016 | 68 | 11 | 79 |
| 2017 | 99 | 15 | 114 |
| 2018 | 104 | 14 | 118 |
| 2019 | 79 | 11 | 90 |
| 2020 | 113 | 14 | 127 |
| 2021 | 107 | 8 | 115 |
| 2022 | 98 | 2 | 100 |
| 2023 | 99 | 5 | 104 |
| 2024 | 78 | 29 | 107 |
| 2025 | 3 | 2 | 5 |
To return to the timeline,
click here.
Below are the most recent publications written about "Neoplasms" by people in Profiles.
-
Development and Implementation of a Personal Virtual Assistant for Patient Engagement and Communication in Postsurgical Cancer Care: Feasibility Cohort Study. JMIR Cancer. 2025 Feb 18; 11:e64145.
-
Next-Generation Sequencing-Based MSI Scoring Predicts Benefit in Mismatch Repair-Deficient Tumors Treated with Nivolumab: Follow-up on NCI-MATCH Arm Z1D. Clin Cancer Res. 2025 Feb 17; 31(4):667-677.
-
Nutrition Security During Cancer: A Qualitative Investigation Among Patients With Cancer on Active Treatment From an Area of Persistent Poverty. Cancer Rep (Hoboken). 2025 Feb; 8(2):e70141.
-
The National Cancer Institute clinical trials planning meeting to address gaps in observational and intervention trials for cancer-related cognitive impairment. J Natl Cancer Inst. 2025 Feb 01; 117(2):217-228.
-
A First-in-Human Study of Cinrebafusp Alfa, a HER2/4-1BB Bispecific Molecule, in Patients with HER2-Positive Advanced Solid Malignancies. Clin Cancer Res. 2025 Jan 17; 31(2):288-298.
-
Association of opioid use with survival in patients with cancer treated with immune checkpoint inhibitors: it is time for evidence-based behaviors. Oncologist. 2025 Jan 17; 30(1).
-
Update on Pediatric Surveillance Recommendations for PTEN Hamartoma Tumor Syndrome, DICER1-Related Tumor Predisposition, and Tuberous Sclerosis Complex. Clin Cancer Res. 2025 Jan 17; 31(2):234-244.
-
Application and Expectations for Immune Checkpoint Blockade of LAG3 and TIGIT. Annu Rev Med. 2025 Jan; 76(1):189-205.
-
Accelerating the Future of Oncology Drug Development: The Role of Consortia in the Delivery of Precision Oncology Early Phase Clinical Trials. J Clin Oncol. 2025 Feb 20; 43(6):735-747.
-
A phase Ia study of a novel anti-HER2 antibody-drug conjugate GQ1001 in patients with previously treated HER2 positive advanced solid tumors. J Transl Med. 2025 Jan 09; 23(1):37.